Pictor Holdings Secures $7.5 Million to Expand Protein Analysis Platform
The funding will support manufacturing and commercial partnerships for a system that analyzes multiple protein targets in less than two hours.
The funding will support manufacturing and commercial partnerships for a system that analyzes multiple protein targets in less than two hours.
Moffitt Cancer Center is partnering with Dicom Systems to scale digital pathology data management using the Unifier Platform, enabling standardized imaging workflows and supporting high-volume slide routing of up to 85,735 slides per day.
The cloud-based system aims to address the bottleneck of translating raw genomic data into actionable information for clinical laboratories.
The collaboration combines AI-based analysis tools with a next-generation sequencing system to support labs performing tumor and liquid biopsy testing.
Read MoreThe collaboration combines Labcorp’s clinical expertise with Lunit’s AI algorithms to analyze tumor microenvironments and enhance biomarker discovery.
Read MoreBloodGPT partners with Smartcare Health Solutions to provide free access to 5,000 Nigerian patients monthly as part of pilot program.
Read MoreThe acquisition adds analytical characterization and molecular design software capabilities to Revvity Signals’ platform.
Read MoreSpaarne Gasthuis deploys cloud-based software to enable primary diagnosis and expand collaboration with subspecialists across regional cancer network.
Read MoreThe update introduces presentation queues, enhanced consult workflows, and speech-driven dictation capabilities for pathology labs.
Read MoreThe CLIA-lab test marks HistoIndex’s expansion from research to routine diagnostics, offering AI-based digital pathology for quantitative liver fibrosis assessment in patients with MASH.
Read MoreResearchers say a closer look inside cells could be used by physicians to detect diseases earlier and better match patients to therapies.
Read MorePartnership with Pictor Labs brings H&E, IHC, and special stains to Concentriq software, aiming to reduce costs and improve workflow efficiency.
Read MoreThe new platform integrates genomic and epigenomic data in a single long-read sequencing assay, providing high-resolution insights into chromatin structure, gene regulation, and disease mechanisms.
Read MoreMount Sinai researchers develop machine learning approach that analyzes common clinical data to determine penetrance of rare genetic variants.
Read MoreThe expansion adds compatibility with Roche’s VENTANA DP 200 and DP 600 scanners and makes AISight Dx the first digital pathology image management system cleared under the FDA’s Predetermined Change Control Plan.
Read MoreProscia is scaling its AI-powered Concentriq pathology platform, driving adoption through a variety of clinical and business benefits.
Read MorePathAI has received FDA 510(k) clearance for its AISight Dx digital pathology platform, enabling its use in primary diagnosis.
Read MorePathAI and Discovery Life Sciences have partnered to deploy AI-powered pathology solutions, providing enhanced digital insights.
Read More